Orphanet: CATALYST: Estudio de la eficacia y la seguridad de bardoxolona metilo en pacientes con hipertensión arterial pulmonar asociada a enfermedad del tejido conectivo Fase III ES completado
x

Search for a clinical trial

* (*) mandatory field

CATALYST: A study of the efficacy and safety of bardoxolone methyl in patients with connective tissue disease-associated pulmonary arterial hypertension (Phase III) - ES (Completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Reata pharmaceuticals
    • Phase : III
  • Principal investigator of clinical trial

  • Dr Pilar ESCRIBANO SUBAS
  • Unidad Multidisciplinar de Hipertensin Pulmonar
  • Servicio de Cardiologa
  • Hospital Universitario 12 de Octubre
  • Avenida de Crdoba s/n
  • 28041 MADRID
  • SPAIN
  • More information
  • Phone  : 
    34 91 390 80 00 ext.4471-4642
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: March 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.